BECN1 and neoplasm: The results demonstrated that low-expressed Beclin 1 was as well an adverse prognostic factor in ovarian carcinoma patients having tumor in grade 1 (P = 0.037), grade 2 (P = 0.011), grade 3 (P = 0.004; Figure 2A), FIGO stage II (P = 0.014, Figure 2B), pT1 (P = 0.001), pT2 (P<0.0001, Figure 2C), pN0 (P = 0.002, Figure 2D), pN1 (P = 0.008, Figure 2D), pMX (P = 0.032, Figure 2E).